Evidence map›Paper›PMID 38628503›Full record

ArticleDEN open2024

Atsushi Kanamori, Yuji Nadatani, Nahoko Kushiyama, Akinobu Nakata, Akira Higashimori, Masaki Ominami, Tatsuo Kimura, Shinya Fukumoto, Yasuhiro Fujiwara, Toshio Watanabe

Open access · goldAbstract readCase ReportsEnglish Abstract
In one paragraph

Article in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Atsushi KanamoriDepartment of Premier Preventive Medicine/MedCity21 Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Yuji NadataniDepartment of Premier Preventive Medicine/MedCity21 Osaka Metropolitan University Graduate School of Medicine Osaka Japan.ORCID https://orcid.org/0000-0001-7081-8746
Nahoko KushiyamaDepartment of Gastroenterology Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Akinobu NakataDepartment of Gastroenterology Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Akira HigashimoriDepartment of Gastroenterology Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Masaki OminamiDepartment of Gastroenterology Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Tatsuo KimuraDepartment of Premier Preventive Medicine/MedCity21 Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Shinya FukumotoDepartment of Premier Preventive Medicine/MedCity21 Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Yasuhiro FujiwaraDepartment of Gastroenterology Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Toshio WatanabeDepartment of Premier Preventive Medicine/MedCity21 Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Osaka Metropolitan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal submucosal hematoma is a rare, often incidental complication of therapeutic endoscopic procedures marked by disrupted blood vessels beneath the esophageal mucosa, forming a hematoma. We report the unique case of a severely thin and alcoholic 38-year-old woman with a history of reflux esophagitis who developed an esophageal submucosal hematoma during an unsedated transnasal endoscopy for health check-up. During the procedure, the patient experienced strong vomiting reflexes and vomited blood, leading to the initial suspicion of either Mallory-Weiss syndrome or epistaxis. However, subsequent sedated endoscopy revealed an esophageal submucosal tumor-like lesion and a mucosal laceration with blood clots, prompting a dual diagnosis of esophageal submucosal hematoma and Mallory-Weiss syndrome. The bleeding was not severe enough to require hemostatic intervention. The patient opted for conservative treatment with vonoprazan, which resulted in the improvement and healing of the hematoma within 28 days. This is the first report of an esophageal submucosal hematoma during transnasal endoscopy and emphasizes the importance of including an esophageal submucosal hematoma and Mallory-Weiss syndrome in the differential diagnosis of hematemesis encountered in similar scenarios. Factors such as severe thinness, daily alcohol consumption, and reflux esophagitis may have possibly contributed to the development of the esophageal submucosal hematoma in this patient.

Identifiers

PMID38628503
PMCPMC11019114
OpenAlexW4394850439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.